Summary of all the Indicators
Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Halozyme Therapeutics’s (RV7) Moving Averages Convergence Divergence (MACD) indicator is 2.11, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (RV7) 20-Day exponential moving average is 69.45, while Halozyme Therapeutics’s (RV7) share price is €73.14, making it a Buy.
Halozyme Therapeutics’s (RV7) 50-Day exponential moving average is 65.88, while Halozyme Therapeutics’s (RV7) share price is €73.14, making it a Buy.
Halozyme (RV7) Pivot Points
Classic
70.50
70.98
71.22
71.70
71.94
72.42
72.66
Fibonacci
70.98
71.26
71.42
71.70
71.98
72.14
72.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Halozyme (RV7) Moving Averages
MA5
72.37Sell
71.77Sell
MA10
70.96Buy
71.02Buy
MA20
69.49Buy
69.45Buy
MA50
64.75Buy
65.88Buy
MA100
60.60Buy
63.13Buy
MA200
60.14Buy
61.55Buy
Halozyme Therapeutics’s (RV7) 10-Day exponential moving average is 71.02, while Halozyme Therapeutics’s (RV7) share price is €73.14, making it a Buy.
Halozyme Therapeutics’s (RV7) 100-Day exponential moving average is 63.13, while Halozyme Therapeutics’s (RV7) share price is €73.14, making it a Buy.
Halozyme Therapeutics’s (RV7) stock price is €73.14 and Halozyme Therapeutics’s (RV7) 50-day simple moving average is 64.75, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €73.14 and Halozyme Therapeutics’s (RV7) 100-day simple moving average is 60.60, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €73.14 and Halozyme Therapeutics’s (RV7) 200-day simple moving average is 60.14, creating a Buy signal.
Halozyme (RV7) Technical Indicators
RSI (14)
63.05
Neutral
STOCH (9,6)
72.28
Neutral
STOCHRSI (14)
82.42
Sell
MACD (12,26)
2.11
Sell
ADX (14)
30.29
Neutral
Williams %R
-24.25
Buy
CCI (14)
80.27
Neutral
ATR (14)
1.08
-
Ultimate Oscillator
61.76
Neutral
ROC
7.94
Buy
Halozyme Therapeutics’s (RV7) Relative Strength Index (RSI) is 63.05, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Trend Strength Indicator (ADX) is 30.29, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Commodity Channel Index (CCI) is 80.27, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Price Rate of Change (ROC) is 7.94, creating a Buy signal.
FAQ
Is RV7 a Buy, Hold, or Sell?
Based on RV7’s technical indicators, RV7 is a Buy.
What is RV7’s RSI (14)?
RV7’s RSI (14) is 63.05, which suggests RV7 is a Neutral.
What is RV7’s MACD?
RV7’s MACD is 2.11, which suggests RV7 is a Sell.
What is RV7’s 5-day moving average?
RV7’s 5-day moving average is 72.37, which suggests RV7 is a Sell.
What is RV7’s 20-day moving average?
RV7 20-day moving average is 69.49, which suggests RV7 is a Buy.
What is RV7’s 50-day moving average?
RV7’s 50-day moving average is 64.75, which suggests RV7 is a Buy.
What is RV7’s 200-day moving average?
RV7’s 200-day moving average is 60.14, which suggests RV7 is a Buy.
What is RV7’s Williams % R (14)?
RV7’s Williams % R (14) is -24.25, which suggests RV7 is a Buy.
What is RV7’s CCI (14)?
RV7’s CCI (14) is 80.27, which suggests RV7 is a Neutral.
What is the share price of Halozyme Therapeutics?
Halozyme's share price is N/A€.